EUVIMEDEUVIMED entdecken
Crossref

Glutathione‐Responsive Two‐Dimensional Nanolock Induces Cuproptosis in Prostate Cancer via Synergistic Chemodynamic‐Photothermal Therapy

Muqi Chen, Wenjie Xie, Jiaquan Xu, Yuexian Yao, Jundong Lin, Biyan Wen, Xiaoyu Lin, Qishan Dai, Fen Zou, Huikang Yang, Zhihao Zou, Qianfeng Xu und 6 weitere

Advanced Healthcare Materials · 16.11.2026

DOI: 10.1002/adhm.71979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 16.11.2026. Verfasst von Muqi Chen und 17 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis, a novel form of programmed cell death induced by intracellular copper overload, provokes mitochondrial tricarboxylic acid (TCA) cycle collapse and metabolic dysfunction. This process can be potentiated by reactive oxygen species (ROS)‐burst strategies, including chemodynamic therapy (CDT) and photothermal therapy (PTT). Given the pronounced reliance of aggressive prostate cancer (PCa) cells on TCA cycle energy metabolism, therapeutic approaches that sensitize malignancies to cuproptosis hold significant promise. This study develops a tumor‐targeted nanolock (HA@CuHPT‐IR780) by coordinating copper ions with a catechol ligand, incorporating the photosensitizer IR780, and functionalizing the surface with hyaluronic acid for enhanced tumor targeting. The nanolock remains stable in a “locked” state under normal physiological conditions but disassembles upon exposure to glutathione (GSH), concurrently depleting GSH while releasing 2,3,6,7,10,11‐hexahydroxytriphenylene (HPT), Cu + , and IR780. Liberated HPT elevates intracellular hydrogen peroxide (H 2 O 2 ) levels, and Cu + converts H 2 O 2 into cytotoxic hydroxyl radicals (•OH) via a Fenton‐like reaction. Near‐infrared (NIR) irradiation further amplifies ROS generation via a photothermal effect and disrupts mitochondrial metabolism to potentiate cuproptosis. In vitro and in vivo experiments confirm cuproptosis induction in PCa cells via synergistic chemodynamic‐photothermal therapy with minimal systemic toxicity. Collectively, this work proposes a promising multimodal therapeutic regimen for advanced PCa.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, M., Xie, W., Xu, J., Yao, Y., Lin, J., Wen, B., Lin, X., Dai, Q., Zou, F., Yang, H., Zou, Z., Xu, Q., Zhong, G., Zhou, H., Luo, P., Han, Z., Zhong, W., & Zhuo, Y. (2026). Glutathione‐Responsive Two‐Dimensional Nanolock Induces Cuproptosis in Prostate Cancer via Synergistic Chemodynamic‐Photothermal Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.71979

Vancouver

Chen M, Xie W, Xu J, Yao Y, Lin J, Wen B, et al. Glutathione‐Responsive Two‐Dimensional Nanolock Induces Cuproptosis in Prostate Cancer via Synergistic Chemodynamic‐Photothermal Therapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.71979

BibTeX
@article{Chen2026,
  author = {Chen, Muqi and Xie, Wenjie and Xu, Jiaquan and Yao, Yuexian and Lin, Jundong and Wen, Biyan and Lin, Xiaoyu and Dai, Qishan and Zou, Fen and Yang, Huikang and Zou, Zhihao and Xu, Qianfeng and Zhong, Guowei and Zhou, Haoran and Luo, Pu and Han, Zhaodong and Zhong, Weide and Zhuo, Yangjia},
  title = {Glutathione‐Responsive Two‐Dimensional Nanolock Induces Cuproptosis in Prostate Cancer via Synergistic Chemodynamic‐Photothermal Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.71979}
}
Kostenlos starten →